Related Experiment Video
Updated: Apr 29, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Macular hole repair by vitrectomy and internal limiting membrane peeling in highly myopic eyes
Lan-Hsin Chuang1, Yen-Po Chen, Nan-Kai Wang
1*Department of Ophthalmology, Chang-Gung Memorial Hospital, Keelung, Taiwan; †Chang Gung University College of Medicine, Taoyuan, Taiwan; and ‡Department of Ophthalmology, Chang-Gung Memorial Hospital, Taoyuan, Taiwan.
Purpose:
To evaluate the surgical outcomes of macular hole (MH) repair by vitrectomy and internal limiting membrane peeling in highly myopic eyes.
Methods:
In this retrospective interventional case series, 30 highly myopic eyes with MH in 29 consecutive patients who underwent vitrectomy and internal limiting membrane peeling to repair MH were studied. The mean follow-up time was 36.4 months. The anatomical outcomes of the MH were evaluated by optical coherence tomography. The best-corrected visual acuities before and after surgery were compared as the functional outcome.
Results:
Women accounted for 69% of MH in highly myopic eyes. The mean age was 49 years. The mean refraction error and mean axial length were -9.80 (± 2.93) diopter and 28.13 (± 2.41) mm, respectively. Myopic foveoschisis was observed in 3 eyes (10%). The MHs were closed by a single surgery in 26 eyes (87%), and the final closure rate was 97% (29/30 eyes). Macular hole surgery significantly improved best-corrected visual acuity from 1.20 ± 0.70 to 0.77 ± 0.51 logarithm of the minimum angle of resolution (P = 0.003). However, rhegmatogenous retinal detachment developed in 3 eyes (10%) during the follow-up.
Conclusion:
Vitrectomy with internal limiting membrane peeling is effective to repair MH in highly myopic eyes in terms of anatomical and functional outcomes, although visual acuity may continue to improve slowly until 3 years after successful MH-closing surgery. In addition, a small proportion of MH cases were associated with myopic foveoschisis. Delayed hole closure and rhegmatogenous retinal detachment may occur in these highly myopic eyes after surgery.
Insights
Vitrectomy with internal limiting membrane peeling effectively repairs macular holes (MH) in highly myopic eyes, improving visual acuity. While successful, potential complications include delayed closure and retinal detachment.
Area of Science:
- Ophthalmology
- Retinal Surgery
- High Myopia Research
Background:
- Macular holes (MH) in highly myopic eyes present unique surgical challenges.
- Standard surgical approaches may have variable outcomes in this patient population.
Purpose of the Study:
- To evaluate the surgical outcomes of macular hole (MH) repair using vitrectomy and internal limiting membrane peeling in eyes with high myopia.
- To assess both anatomical and functional results of this surgical technique.
Main Methods:
- A retrospective interventional case series included 30 highly myopic eyes from 29 patients undergoing vitrectomy and internal limiting membrane peeling for MH repair.
- Optical coherence tomography assessed anatomical outcomes, while best-corrected visual acuity (BCVA) changes evaluated functional outcomes.
- Mean follow-up was 36.4 months.
Main Results:
- The final MH closure rate was 97% (29/30 eyes), with 87% achieving closure after a single surgery.
- BCVA significantly improved from 1.20 to 0.77 logMAR (P = 0.003).
- Complications included rhegmatogenous retinal detachment in 10% of eyes; myopic foveoschisis was noted in 10%.
Conclusions:
- Vitrectomy with internal limiting membrane peeling is an effective surgical strategy for MH repair in highly myopic eyes, yielding positive anatomical and functional results.
- Visual acuity may show slow improvement up to three years post-surgery.
- Potential risks include delayed hole closure and rhegmatogenous retinal detachment, particularly in eyes with associated myopic foveoschisis.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview

